News
The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...
The complete response (CR) rate at 1 month improved from 25% with single-fraction conformal 3D RT (3D-CRT) to 37% with SBRT, ...
In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or ...
Food allergy in children with atopic dermatitis is associated with an increased risk for asthma, allergic rhinitis, and ...
European governments are examining whether U.S. President Donald Trump can force them to pay more for prescription medicines, ...
A consultancy’s new ranking of drug company R&D shows Eli Lilly has risen to the top of the drug development heap, while ...
Explore more
Controlling the entire cell therapy production process—from material receipt to product release—is “essential,” according to AstraZeneca, which says its new $300 million manufacturing facility will be ...
Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated ...
Scientists at EPFL and AstraZeneca have developed a method to map the atomic-level structure of amorphous drugs, demonstrated ...
In 2024 alone, Singapore secured S$13.5 billion in fixed asset investment commitments, with the biomedical sector ...
The ruling, seen as a major victory for transparency campaigners, piles pressure on Ursula von der Leyen over the opaque nature of the EU's vaccine negotiations during the pandemic.
In this video, Ursula A. Matulonis, MD, discusses preliminary efficacy and safety results for puxitatug samrotecan in patients with recurrent endometrial cancer.Findings from a phase 1/2a study of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results